• 1
    Tao CM, Huang TY, Feng PF et al. A preliminary study on hepatitis B vaccine. Chin Med J (Engl) 1978; 4: 101110.
  • 2
    Buynak EB, Roehm RR, Tytell AA, Bertland AU, Lampson GP, Hilleman MR. Vaccine against human hepatitis B. JAMA 1976; 235: 28322834.
  • 3
    Mo ZJ, Shen LP, Yang JY et al. Study on the relationship between hepatitis B vaccination and sero-epidemiology of infective status of hepatitis B virus. Chin J Vaccine Immun (Chin) 2007; 13: 216218.
  • 4
    Tian C, Ma JC, Han CZ et al. Infective status of HBV among population after 19 years immunization vaccine. Chin J Vaccine Immun (Chin) 2007; 13: 47.
  • 5
    Liang X, Bi S, Yang W et al. Epidemiological serosurvey of hepatitis B in China – Declining HBV prevalence due to Hepatitis B vaccination. Vaccine 2009; 27: 65506557.
  • 6
    Zhuang H. Challenge of chronic hepatitis B in China. Chin J Infect Dis (Chin) 2005; 23(Suppl.): 25.
  • 7
    Zhang J, Zhao Z, Shao X, Zou Y. Hepatitis B seroepidemic survey in Guangdong province in 2006. South China J Prev Med (Chin) 2009; 35: 3840.
  • 8
    Lu F, Zhuang H. Management of hepatitits B in China. Chin Med J (Engl) 2009; 122: 34.
  • 9
    Qu ZY. An epidemiological study on the distribution of HBsAg and anti-HBs in China. Chinese J Microbiol Immunol (Chin) 1986; 6: S20S40.
  • 10
    Hu ZH, Qu ZY, Jing Q et al. The overall infection rate of HBV in Chinese general population by sampling investigation. Chinese J Microbiol Immunol (Chin) 1986; 6: S70S77.
  • 11
    Liu CB, Xu ZY, Cao HL et al. Sero-epidemiology of HBV infection in four provinces in China. Chinese J Virol (Chin) 1991; 7: S8S14.
  • 12
    Xia GL, Liu CB, Cao HL et al. Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D and E virus infections in China, 1992. Int Hepatol Commun 1996; 5: 6273.
  • 13
    Dai ZC, Qi GM. Seroepidemiological Survey on Viral Hepatitis in China (part one), 1st edn. Beijing: Sci Tech Literature Publishing House, 1997 59.
  • 14
    Liang X, Bi S, Yang W et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992–2005 in China. J Infect Dis 2009; 200: 3947.
  • 15
    Data on 2006 seroepidemiological survey on HBV infection in China. Available at (accessed 21 April 2008).
  • 16
    Wang FZ, Cui FQ, Lu Y et al. Analysis on reported hepatitis B cases on pilot surveillance in 18 counties of 8 provinces of China. Chin J Vaccine Immun (Chin) 2007; 13: 309331.
  • 17
    Cui FQ, Wang XJ, Liang XF. Epidemiological analysis on reported hepatitis B under 15 years in China: the report from Chinese Center for Disease Control and Prevention. Chin J Vaccine Immun (Chin) 2006; 12: 206208.
  • 18
    Zhou YH, Wu C, Zhuang H. Vaccination against hepatitis B: the Chinese experience. Chin Med J (Engl) 2008; 121: 98102.
  • 19
    Gong XH, Liu LR, Jia L, Li YH, Xing YL, Wang QY. Epidemiological effect of hepatitis B immunization among newborn babies in Beijing. Chin J Hepatol (Chin) 2003; 11: 201202.
  • 20
    Zhang HW, Yin JH, Li YT et al. Risk factors for acute hepatitis B and its progression to chronic hepatitis in Shanghai, China. Gut 2008; 57: 17131720.
  • 21
    Gong J, Li RC, Yang JY et al. Long-term efficacy of infant hepatitis B immunization program. Chin J Hepatol (Chin) 2003; 11: 203205.
  • 22
    Wang ST, Wong XZ. Report of 5 cases of post transfusion serum hepatitis. J Peking Univ (Health Sci) (Chin) 1960; 2: 6366.
  • 23
    Shang G, Seed CR, Wang F, Nie D, Farrugia A. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004. Transfusion 2007; 47: 529539.
  • 24
    Liang RL, Su QT. A study on HBV horizontal transmission between spouses. Zhong Hua Liu Xing Bing Xue Za Zhi 1984; 5(6): 372374.
  • 25
    Alter MJ, Margolis HS. The emergence of hepatitis B as a sexually transmitted disease. Med Clin North Am 1990; 74: 15291541.
  • 26
    Wu Q, Li Z, Fan J. A seroepidemiological study on sexually transmitted HBV infection. Chin J Epidemiol (Chin) 1994; 15: 6770.
  • 27
    Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004; 11: 97107.
  • 28
    Jia JD. Hepatitis B in China: from Guideline to Practice. Virol Sin 2008; 23: 152155.
  • 29
    Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci 2005; 2: 5057.
  • 30
    Zhu JM, Li BK. Current status of unsafe injection of Chinese countryside. Chin J Dis Control Prev (Chin) 2004; 8: 247249.
  • 31
    Murakami H, Kobayashi M, Zhu X et al. Risk of transmission of hepatitis B virus through childhood immunization in northwestern China. Soc Sci Med 2003; 57: 18211823.
  • 32
    Zuo JT, Zhong G, Lan GH et al. Epidemiological retrospective experimental study on HBV transmission with unsafe injection in Guangxi, China. Chin J Vaccine Immun (Chin) 2006; 12: 140142.
  • 33
    Wang NS, Lan YJ, Tang LQ, Liao FT. Analysis of hepatitis B virus and hepatitis C virus infection in patients with maintenance hemodialysis. Chin J Nephrol (Chin) 1998; 14: 376379.
  • 34
    Ma LL, Sun Y, Li XW. An epidemiology study of HBV infection in hemodialysis center. Chin J Blood Purif (Chin) 2006; 5: 265268.
  • 35
    Hsu YS, Chien RN, Yeh CT et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002; 35: 15221527.
  • 36
    Yang HI, Lu SN, Liaw YF et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002; 347: 168174.
  • 37
    Yang CG, Yu LC, Chen JJ et al. A comparison of clinical and virological characteristics of 1686 cases of HBeAg negative and HBeAg positive chronic hepatitis B. Chin J Intern Med (Chin) 2005; 44: 648651.
  • 38
    Lin HH, Wang LY, Hu CT et al. Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: sixteen years after newborn vaccination program in Taiwan. J Med Virol 2003; 69: 471474.
  • 39
    Chang MH, Chen CJ, Lai MS et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997; 336: 18551859.
  • 40
    Li RC, Yang JY, Gong J et al. Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma. Chin J Epidemiol (Chin) 2004; 25: 385387.
  • 41
    Lu FM, Zhuang H. Prevention of hepatitis B in China: achievements and challenges. Chin Med J (Engl) 2009; 122: 29252927.